"Tivikay" (dolutegravir): nke price ogbo. Ebe ịzụta ọnụ ala karịa Tivikay

Nkwadebe "Tivikay" bụ integrase inhibitor nke nke abụọ emana, na a na-eji maka ọgwụgwọ nke HIV. Ya isi nọ n'ọrụ mgwa - dolutegravir - patented site ViiV Healthcare. Ọ bụ ike jide enzyme na catalyzes mwekota nke HIV n'ime chromosome nke mmadụ niime ụlọnga. Ngwá ọrụ a na-atụ aro maka ọrịa ndị na-adịghị natara tupu ọgwụ, na maka ndị nwere ahụmahụ nke HAART.

N'ebe o kwere mee ọgwụ "Tivikay" ịzụta ọnụ ala

Kọwara nkwadebe - bụ ngwá ọrụ dị irè na-alụso HIV. Ọ bụ ike normalize ọnọdụ nke onye ọrịa, belata ịta nke malitere ịrịa RNA na plasma ma budata belata ihe ize ndụ nke nsogbu.

Ma "Tivikay" mbadamba price na Moscow ẹkenịmde n'ime 25 000 rubles. mbukota, na ebe ọ bụ na nke a ọgwụ ga-ewere a ogologo oge, ihe omume ha nwere ike budata kụrụ onye ọrịa ahụ n'akpa uwe. Ná mmalite 2017 India ụlọ ọrụ HETERO mara ọkwa mwepụta nke amụba "Tivikay" ọnyà na mpaghara dị ka «DOLUVIR». Home sales generics na India bụ nyeere ọtụtụ ndị bu nje HIV onye regimens bụ bụzi ihe mgbe ochie ma ọ bụ na-adịghị eweta chọrọ mmetụta. Ugbua, n'ihi na ndị na-achọ "Tivikay" ịzụta na a ala price, ọ bụ ike ịzụta ya na WWW.ARV24.NET - Online Indian soplaya nke ọgwụ.

Ebe i nwere ike ịzụta ọnyà ọgwụ ọjọọ - n'aka ikikere na-enwe yiri na-ewere ọgwụ ọjọọ na-arụsi ọrụ ike mgwa. Ala na-eri ọnyà kọwara site na eziokwu na ya ntọhapụ na ụlọ ọrụ na-mkpa na-eji ego na mmepe, nnyocha na mkpọsa. All nke a, karị, na-enye ha ohere ka a uru na a ukwuu ala retail price nke ọgwụ ọjọọ.

Iji na onunu ogwu

Mbadamba "Tivikay" e kenyere na Nchikota na ndị ọzọ ọgwụ ọjọọ eme ihe maka ọgwụgwọ nke HIV-1 ọrịa ma okenye ọrịa na ụmụ nke afọ 12, na a arọ ahụ n'elu 40 n'arọ.

A na-akpọ ọgwụ e nyere site na a ọkachamara. Ọ na-e enweghị banyere nri. The dose akwadoro maka ọrịa na-adịghị enwe iguzogide isi bụ 50 mg otu ugboro n'ụbọchị. Na ndị dị otú ahụ na-enyo enyo ma ọ bụ akwukwo, 50 mg kewara 2 doses.

Ọ bụrụ na n'ikuku "Tivikay" Erere bụ n'ihi ihe ụfọdụ na-efu, ị ga-ewere ya dị ka n'oge na-adịghị dị ka o kwere omume, ọ bụrụhaala na e nwere ihe na-erughị awa anọ tupu ọzọ ochichi. Ma ọ bụghị ya mma ichere maka ọzọ n'ikuku oge na ẹdude oge.

contraindications

Dị na nkwadebe "Tivikay" reviews akọwa ngwá ọrụ na-ukwuu irè ma na-enwe elu fọrọ eguzogide. Ma nzube nke ngwá ọrụ a nwere na-agaghị emeli. N'ihi ya, mbadamba anaghị emetụta na ikpe nke:

• hypersensitivity ha Isi nọ n'ọrụ mgwa (dolutegraviru) ma ọ bụ ka ndị ọzọ mmiri nke ọgwụ;
• mkpa iji pụtara gụnyere dofetilide;
• na afọ nke 12 afọ na a arọ ahụ erughị 40 n'arọ.

Nlezianya kwadebe a na-eji mgbe onye ọrịa nwere oké imeju ọrụ ọrịa.

mmetụta

Oghom mmetụta na pụrụ ibilite mgbe n'ikuku "Tivikay" mkpụrụ ọgwụ na-agụnye ndị na-esonụ:

• afọ ọsịsa;
• ọgbụgbọ, na-esokarị site vomiting;
• flatulence;
• abdominal mgbu (ke n'elu akụkụ);
• isi ọwụwa;
• doro anya nrọ;
• ehighị ụra nke ọma;
• dizziness;
• akpụkpọ ọkụ ọkụ na itching;
• ike ọgwụgwụ.

Ebe ọ bụ na ojiji nke dolutegravira nwere ike ime ka opportunistic na-efe efe ma ọ bụ ndị ọzọ nsogbu, na ọgwụgwọ nke na aha nke gị n'ụlọnga ga-ebe naanị n'okpuru ike nlekọta nke a ọkachamara nwere ahụmahụ n'imeso HIV.